New ALS Treatment, AMX0035, No Evidence of Benefit, FDA Panel

[ad_1]

By a vote of 6-4, the agency’s group of independent counselors concluded that the results of another clinical trial were necessary to evaluate whether the treatment, called AMX0035, would help patients.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

/** * The template for displaying the footer * * Contains the closing of the #content div and all content after. * * @link https://developer.wordpress.org/themes/basics/template-files/#template-partials * * @package BeShop */ $beshop_topfooter_show = get_theme_mod( 'beshop_topfooter_show', 1 ); $beshop_basket_visibility = get_theme_mod( 'beshop_basket_visibility', 'all' ); ?>